Stay updated with breaking news from Aritzon Advisory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
27.06.2022 Defence Therapeutics Inc.: DEFENCE REPORTS EFFECTIVE CONTROL OF CERVICAL CANCER GROWTH IN RESPONSE TO ITS ACCUVAC-PT007 THERAPEUTIC VACCINATION | Defence Therapeutics Inc. | News | Nachricht | Mitteilung
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized
DGAP-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDefence Therapeutics Inc.: DEFENCE REPORTS EFFECTIVE CONTROL OF CERVICAL CANCER GROWTH IN RESPONSE TO ITS ACCUVAC-PT007 THERAPEUTIC VACCINATION 27.06.2022 / 08:00 The issuer is solely responsible for the content of this announcement.CSE: DTC FSE: DTC U...